A multimodality localization technique for radio-guided surgery

Por Gulec, Seza A, Hoenie, Erica, Rheinheimer, Kristan
Publicado em 2007

Optimization of FDG-PET/CT imaging protocol for evaluation of patients with primary and metastatic liver disease

Por Kuker, Russ A, Mesoloras, Geraldine, Gulec, Seza A
Publicado em 2007

Preoperative Y-90 microsphere selective internal radiation treatment for tumor downsizing and future liver remnant recruitment: a novel approach to improving the safety of major he...

Por Gulec Seza A, Pennington Kenneth, Hall Michael, Fong Yuman
Publicado em 2009-01-01

PET probe-guided surgery: applications and clinical protocol

Por Gulec, Seza A, Hoenie, Erica, Hostetter, Richard, Schwartzentruber, Douglas
Publicado em 2007

Preoperative Y-90 microsphere selective internal radiation treatment for tumor downsizing and future liver remnant recruitment: a novel approach to improving the safety of major he...

Por Gulec, Seza A, Pennington, Kenneth, Hall, Michael, Fong, Yuman
Publicado em 2009

Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow...

Por Gulec, Seza A, Mesoloras, Geraldine, Dezarn, William A, McNeillie, Patrick, Kennedy, Andrew S
Publicado em 2007

Biological Factors, Tumor Growth Kinetics, and Survival After Metastasectomy for Pulmonary Melanoma

Por Lee, Jonathan H, Gulec, Seza A, Kyshtoobayeva, Ainura, Sim, Myung, Morton, Donald L
Publicado em 2009

18F-FLT Positron Emission Tomography/Computed Tomography Imaging in Pancreatic Cancer: Determination of Tumor Proliferative Activity and Comparison with Glycolytic Activity as Meas...

Por Debebe, Senait Aknaw, Goryawala, Mohammed, Adjouadi, Malek, Mcgoron, Anthony J., Güleç, Seza A.
Publicado no Mol Imaging Radionucl Ther (2016)

(90)Y SPECT/CT quantitative study and comparison of uptake with pretreatment (99 m)Tc‐MAA SPECT/CT in radiomicrosphere therapy

Por Debebe, Senait Aknaw, Adjouadi, Malek, Gulec, Seza A., Franquiz, Juan, McGoron, Anthony J.
Publicado no J Appl Clin Med Phys (2019)

Treatment of Advanced Pancreatic Carcinoma with (90)Y-Clivatuzumab Tetraxetan: A Phase I Single-Dose Escalation Trial

Por Gulec, Seza A., Cohen, Steven J., Pennington, Kenneth L., Zuckier, Lionel S., Hauke, Ralph J., Horne, Heather, Wegener, William A., Teoh, Nick, Gold, David V., Sharkey, Robert M., Goldenberg, David M.
Publicado em 2011

Fractionated Radioimmunotherapy With (90)Y-Clivatuzumab Tetraxetan and Low-Dose Gemcitabine Is Active in Advanced Pancreatic Cancer

Por Ocean, Allyson J., Pennington, Kenneth L., Guarino, Michael J., Sheikh, Arif, Bekaii-Saab, Tanios, Serafini, Aldo N., Lee, Daniel, Sung, Max W., Gulec, Seza A., Goldsmith, Stanley J., Manzone, Timothy, Holt, Michael, O’Neil, Bert H., Hall, Nathan, Montero, Alberto J., Kauh, John, Gold, David V., Horne, Heather, Wegener, William A., Goldenberg, David M.
Publicado em 2012